4-[(2S)-2-[(2S)-2-[(2S)-2-[4-(Guanidinomethyl)piperidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-N-(3-oxazol-5-ylphenyl)-4-oxo-butanamide

ID: ALA5194506

Chembl Id: CHEMBL5194506

PubChem CID: 168284281

Max Phase: Preclinical

Molecular Formula: C35H47N9O6

Molecular Weight: 689.82

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCC1CCN(C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)CCC(=O)Nc2cccc(-c3cnco3)c2)CC1

Standard InChI:  InChI=1S/C35H47N9O6/c36-35(37)39-20-23-12-17-41(18-13-23)32(47)26-7-3-15-43(26)34(49)28-9-4-16-44(28)33(48)27-8-2-14-42(27)31(46)11-10-30(45)40-25-6-1-5-24(19-25)29-21-38-22-50-29/h1,5-6,19,21-23,26-28H,2-4,7-18,20H2,(H,40,45)(H4,36,37,39)/t26-,27-,28-/m0/s1

Standard InChI Key:  DQFLGZKQGWZVON-KCHLEUMXSA-N

Alternative Forms

  1. Parent:

    ALA5194506

    ---

Associated Targets(Human)

NCF1 Tbio Neutrophil cytosol factor 1 (245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 689.82Molecular Weight (Monoisotopic): 689.3649AlogP: 1.75#Rotatable Bonds: 10
Polar Surface Area: 198.27Molecular Species: BASEHBA: 8HBD: 4
#RO5 Violations: 1HBA (Lipinski): 15HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.90CX Basic pKa: 12.14CX LogP: -1.37CX LogD: -3.68
Aromatic Rings: 2Heavy Atoms: 50QED Weighted: 0.21Np Likeness Score: -1.02

References

1. Garsi JB, Komjáti B, Cullia G, Fejes I, Sipos M, Sipos Z, Fördős E, Markacz P, Balázs B, Lancelot N, Berger S, Raimbaud E, Brown D, Vuillard LM, Haberkorn L, Cukier C, Szlávik Z, Hanessian S..  (2022)  Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics.,  13  (6.0): [PMID:35707140] [10.1021/acsmedchemlett.2c00094]

Source